依达拉奉联合灯盏细辛治疗急性脑梗死的临床研究  

Clinical study of the effects of Edaravone and Fleabane in treatment of acute brain infarction

作　　者：黄庆梅[1] 

机构地区：[1]深圳市龙岗中心医院神经内科,广东省深圳518116

出　　处：《中国基层医药》2009年第7期1236-1237,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的探讨依达拉奉联合灯盏细辛治疗急性脑梗死的疗效。方法将急性脑梗死患者80例随机分为依达拉奉联合灯盏细辛治疗组（观察组）和灯盏细辛组（对照组）各40例，分别对两组治疗前、治疗14d后的神经功能缺损评分及临床疗效进行评价。结果治疗后两组神经功能缺损评分较治疗前均有显著改善（P〈0．01），观察组与对照组差异有统计学意义（P〈0．01）；有效率治疗组为82．5％，对照组67．5％，两组差异有统计学意义（P〈0．05）。结论依达拉奉联合灯盏细辛是治疗急性脑梗死安全有效的方法。Objective To observe the effects of Edaravone and Fleabane in treatment of acute cerebral infarction（ACI）. Methods 80 cases of patients with ACI were divided into two groups randomly. The treatment group （n =40） was treated by Edaravone and Fleabane, and the control group（ n = 40） was treated by Fleabane. Before and 14 days after treatment, the neurologic impairment and clinical curative effect of the two groups were evaluated respectively. Results After treatment the neurologic impairment in the two groups were all improved significantly （P 〈 0. 01 ）, and the difference between the two groups was significant （P 〈 0. 01 ）. About the clinical curative effect, the effective rate in the treatment group was 82. 5%, and that in the control group was 67.5%. The difference between the two groups was significant （P 〈 0. 05）. Conclusion Edaravone and Fleabane in treatmem of ACI is safe and effective.

关 键 词：脑梗死 依达拉奉 灯盏细辛 

分 类 号：R74[医药卫生—神经病学与精神病学]